China Medical Imaging Market Size, Share & Trends Analysis Report By Modality (X-ray, Ultrasound, Computed Tomography, Magnetic Resonance Imaging, Nuclear Medicine), By End-use (Hospitals, Diagnostic Imaging Centers), And Segment Forecasts, 2023 - 2030

Report Overview

TheChina medical imaging market sizewas estimated atUSD 1.6 billion in 2022and is estimated to grow at a compound annual growth rate (CAGR) of 6.2% from 2023 to 2030. Key growth drivers for the market include an increasing demand for early detection & prevention of chronic diseases, as well as a growing geriatric population. Technological advancements inmedical imagingfurther contribute to the utilization of advanced techniques to meet healthcare needs. For instance, in June 2023, GE HealthCare announced the FDA approval and launch of Sonic DL, a deep learning-based technology specifically designed to significantly accelerate MRI image acquisition.

The growing prevalence of chronic diseases plays a significant role in driving the demand for medical imaging devices in China. As chronic diseases such as diabetes, cancer, and cardiovascular conditions become more common, the need for accurate and timely diagnosis increases. Medical imaging devices, such asX-ray, MRI, and CT scans, provide valuable insights into the progression and severity of these chronic diseases. They aid healthcare professionals in detecting and monitoring disease markers, guiding treatment decisions, and evaluating treatment effectiveness. By enabling early detection, precise diagnosis, and effective disease management, medical imaging devices contribute to improved patient outcomes and better quality of life for individuals living with chronic diseases.

政府计划在舞会中起到至关重要的作用oting the use of medical imaging devices. By implementing policies and programs that prioritize healthcare infrastructure development, governments encourage the adoption and accessibility of advanced imaging technologies. Funding support, tax incentives, and reimbursement schemes encourage healthcare facilities to invest in medical imaging devices, leading to the improvement and establishment of imaging centers. These initiatives have a positive impact on patient care by increasing access to accurate and timely diagnoses, improving outcomes, and enhancing overall healthcare services for the population. For instance, the government of China has approved the Healthy China 2030 plan, which prioritizes health and aims to participate in global health governance.This initiative is also favorable to market growth.

技术进步在drivin至关重要g the use of medical imaging devices. Continuous advancements in imaging technologies, such as better image quality and faster scans, help doctors diagnose patients more accurately. Advanced imaging methods, such asMRI, CT scans, and PET scans, provide detailed and precise information about the body's structures and any abnormalities present. This allows healthcare professionals to make better treatment plans and monitor progress effectively. Furthermore, advancements such as artificial intelligence (AI) and machine learning (ML) help automate processes and analyze images more efficiently. For instance, Koninklijke Philips N.V. launched Philips CT 3500 computed tomography scanner in May 2023 to expand the market by offering state-of-the-art solutions for routine radiology and high-volume screening programs.

Modality Insights

Ultrasound dominated the product segment with 29.06% of the China medical imaging market share in 2022. This segment is subdivided into 2D, 3D/4D, and Doppler. The 3D/4D segment held the largest revenue share of 38.9% in 2022. Ultrasound with3Dand 4D imaging is used in pregnancy to see a real-time picture of the baby's features and movements. Ultrasound is majorly used in gynecology for the screening and diagnosing of female reproductive organs and diseases such as endometriosis, pelvic inflammatory disease, and reproductive organ cancer.

The increasing demand for ultrasound imaging is driven by several factors. Ultrasound is a safe and non-invasive imaging technique that does not involve radiation exposure, making it preferred for pregnant women and children. It is also widely available and more affordable compared to other imaging methods, making it accessible to more people. Advancements in ultrasound technology have improved image quality, allowing better visualization of internal structures and accurate diagnosis of medical conditions.

Ultrasound is versatile and can be used to assess various body parts and systems, including the abdomen, heart, and blood vessels. With the rising prevalence of chronic diseases, there is a growing need for regular monitoring and early detection, driving the demand for ultrasound as a reliable and effective imaging tool. Its benefits in terms of safety, accessibility, versatility, and accuracy contribute to the increasing demand for ultrasound imaging.

Thecomputed tomography(CT) scanners segment is expected to grow at the fastest CAGR of 8.3% during the forecast period. Technological advancements in CT technology, coupled with the growing prevalence of chronic disorders such as cancer, orthopedics, and cardiovascular and neurological conditions are expected to accelerate the market growth over the forecast period.

End-use Insights

Based on end-use, the China medical imaging market has been segmented into hospitals, diagnostic imaging centers, and others. The hospitals segment held the largest revenue share of around 39.47% in 2022. The growing demand for more accurate diagnostic tools, advancements in imaging technology, expanding healthcare infrastructure, increased awareness about the benefits of early disease detection, and the rising prevalence of chronic diseases. These factors collectively contribute to the rising utilization of medical imaging devices across various medical specialties and healthcare settings.

The diagnostic imaging centers segment is expected to witness the fastest CAGR of 6.14% over the forecast period.The increasing demand for timely and accurate diagnoses has led to a rise in the number of imaging tests performed at dedicated centers, diagnostic imaging centers often have access to advanced imaging technologies and specialized expertise, attracting patients seeking comprehensive diagnostic services. Additionally, advancements in imaging technology have made it more convenient and cost-effective for healthcare providers to outsource imaging services to these centers, further driving their growth.

Key Companies & Market Share Insights

The market is highly consolidated, with the presence of several small and large manufacturers. Competitive rivalry and degree of competition in the China medical imaging market are expected to grow over the forecast period due to the presence of many players in the market. Furthermore, leading players are involved in collaborations, product launches, and mergers & acquisitions to strengthen their product portfolios. For instance, in January 2023, GE HealthCare announced the agreement to acquire a France-based company IMACTIS, an innovator in the quickly expanding area of computed tomography (CT) interventional guide across a variety of healthcare settings. Some prominent players in the China medical imaging market include:

• GE HealthCare

• Siemens Healthcare GmbH

• Koninklijke Philips N.V.

• CANON MEDICAL SYSTEMS CORPORATION

• Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

• Shanghai United Imaging Healthcare Co., Ltd.

China Medical Imaging Market Report Scope

Report Attribute	Details
Market size value in 2023	USD 1.8 billion
Revenue forecast in 2030	USD 2.7 billion
Growth rate	CAGR of 6.2% from 2023 to 2030
Base year for estimation	2022
Historical data	2018 - 2021
Forecast period	2023 - 2030
Quantitative units	Revenue in USD million/billion and CAGR from 2023 to 2030
Report coverage	Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments covered	Modality, end-use
Country scope	China
Key companies profiled	GE HealthCare; Siemens Healthcare GmbH; Koninklijke Philips N.V.; Canon Medical Systems Corporation; Shenzhen Mindray Bio-Medical Electronics Co., Ltd.; Shanghai United Imaging Healthcare Co., Ltd.
Customization scope	Free report customization (equivalent up to 8 analysts’ working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs.Explore purchase options

China Medical Imaging Market Report Segmentation

This report forecasts revenue growth at the country level and provides an analysis of the latest trends and opportunities in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the China medical imaging market report based on product and end-use:

• Modality Outlook (Revenue, USD Million, 2018 - 2030)

  • X-ray

    • Radiography

    • Fluoroscopy

    • Mammography

  • Ultrasound

    • 2D

    • 3 d / 4 d

    • Doppler

  • Computed Tomography (CT)

    • High slice

    • Mid slice

    • Low slice

    • Cone beam

  • Magnetic Resonance Imaging (MRI)

    • Low - strength

    • Mid - strength

    • High - strength

  • Nuclear Medicine

    • SPECT

    • PET

• End-use Outlook (Revenue, USD Million, 2018 - 2030)

  • Hospitals

  • Diagnostic Imaging Centers

  • Others